New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2022, WHO guidelines for malaria, 25 November 2022.
View latest version (2022)Bibliographic information
GuidelineGuidelines for the treatment of malaria
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Retired
Originally developed
Treat children and adults with uncomplicated P. falciparum malaria (except pregnant women in their first trimester) with one of the following artemisinin-based combination therapies (ACT):
- artemether + lumefantrine
- artesunate + amodiaquine
- artesunate + mefloquine
- dihydroartemisinin + piperaquine
- artesunate + sulfadoxine–pyrimethamine (SP).
Recommended in favor
Strong
Certainty of evidence
High
Notes and Remarks
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO guidelines for malaria, 16 February 2021.
Year2021
InstitutionWHO
Guideline
WHO guidelines for malaria, 13 July 2021.
Year2021
InstitutionWHO
Guideline
WHO guidelines for malaria, 18 February 2022.
Year2022
InstitutionWHO
Guideline
WHO guidelines for malaria, 31 March 2022.
Year2022
InstitutionWHO
Guideline
WHO guidelines for malaria, 3 June 2022.
Year2022
InstitutionWHO